Inpare ApS: Financial statements 2017
CVR: 37138789
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Inpare ApS (CVR 37138789) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -167,684 and a net result of DKK -133,096. Equity in the 2017 report amounted to DKK -6,492.
- Revenue
- DKK 0
- Gross Profit
- DKK -167,684
- Profit/Loss
- DKK -133,096
- Equity
- DKK -6,492
- Total Assets
- DKK 59,572
- Employees
- 0
Official annual report
Keep an eye on Inpare ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Inpare ApS has published its interim report for the period September 24, 2015 to December 31, 2016.
About Inpare ApS
Inpare ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 27 November 2024. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Lionheart Pharmaceuticals ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -218,796 and a net result of DKK -272,847 compared with DKK -142,714 the year before. Equity in the 2023 report amounted to DKK -735,535.